# Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device

> **NCT06099106** · NA · RECRUITING · sponsor: **Endomatic Ltd.** · enrollment: 15 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** SEPIOLA System

## Key facts

- **NCT ID:** NCT06099106
- **Lead sponsor:** Endomatic Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2026-06
- **Final completion:** 2027-05
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06099106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06099106, "Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06099106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*